Pasar al contenido principal

APROXIMACIONES ESTRUCTURALES Y FUNCIONALES A LOS MECANISMOS MOLECULARES DEPENDIENTES DE CITOCROMO C QUE REGULAN LA ACTIVIDAD DE LAS CHAPERONAS DE HISTONAS BAJO DAÑO EN EL ADN

PGC2018-096049-B-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de Generación de Conocimiento y Fortalecimiento Científico y Tecnológico del Sistema de I+D+i
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D (Excelencia / Generación de Conocimiento)
Año convocatoria 2018
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Proposed mechanism for regulation of H2O2-inducedprogrammed cell death in plants by binding of cytochrome cto 14-3-3 proteins

  • Elena-Real, Carlos A.
  • González-Arzola, Katiuska
  • Pérez-Mejías, Gonzalo
  • Díaz-Quintana, Antonio
  • Velázquez-Campoy, Adrián
  • Desvoyes, Bénédicte
  • Gutiérrez Armenta, Crisanto
  • Rosa, Miguel A. de la
  • Díaz-Moreno, Irene
12 pags., 6 figs., Programmed cell death (PCD) is crucial for development and homeostasis of all multicellular organisms. In human cells, the double role of extra‐mitochondrial cytochrome c in triggering apoptosis and inhibiting survival pathways is well reported. In plants, however, the specific role of cytochrome c upon release from the mitochondria remains in part veiled yet death stimuli do trigger cytochrome c translocation as well. Here, we identify an Arabidopsis thaliana 14‐3‐3ι isoform as a cytosolic cytochrome c target and inhibitor of caspase‐like activity. This finding establishes the 14‐3‐3ι protein as a relevant factor at the onset of plant H2O2‐induced PCD. The in vivo and in vitro studies herein reported reveal that the interaction between cytochrome c and 14‐3‐3ι exhibits noticeable similarities with the complex formed by their human orthologues. Further analysis of the heterologous complexes between human and plant cytochrome c with plant 14‐3‐3ι and human 14‐3‐3ε isoforms corroborated common features. These results suggest that cytochrome c blocks p14‐3‐3ι so as to inhibit caspase‐like proteases, which in turn promote cell death upon H2O2 treatment. Besides establishing common biochemical features between human and plant PCD, this work sheds light onto the signaling networks of plant cell death., Fundación Banco Santander Spanish Ministry of Education, Culture and Sport. Grant Number: FPU17/04604 Fundación Ramón Areces Fundación Cámara – University of Seville Spanish Ministry of Economy and Competitiveness. Grant Numbers: BFU2015‐71017/BMC MINECO/FEDER, PGC2018‐096049‐B‐I00 BIO/BMC MICINN/FEDER, RTI2018‐094793‐B‐I00 MICIU Andalusian Government. Grant Numbers: BIO198, US‐1257019, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lysosomes: multifunctional compartments ruled by a complex regulatory network

  • Martínez-Fábregas, Jonathan
  • Tamargo-Azpilicueta, Joaquín
  • Díaz-Moreno, Irene
17 p., More than 50 years have passed since Nobel laureate Cristian de Duve described for the first time the presence of tiny subcellular compartments filled with hydrolytic enzymes: the lysosome. For a long time, lysosomes were deemed simple waste bags exerting a plethora of hydrolytic activities involved in the recycling of biopolymers, and lysosomal genes were considered to just be simple housekeeping genes, transcribed in a constitutive fashion. However, lysosomes are emerging as multifunctional signalling hubs involved in multiple aspects of cell biology, both under homeostatic and pathological conditions. Lysosomes are involved in the regulation of cell metabolism through the mTOR/TFEB axis. They are also key players in the regulation and onset of the immune response. Furthermore, it is becoming clear that lysosomal hydrolases can regulate several biological processes outside of the lysosome. They are also implicated in a complex communication network among subcellular compartments that involves intimate organelle-to-organelle contacts. Furthermore, lysosomal dysfunction is nowadays accepted as the causative event behind several human pathologies: low frequency inherited diseases, cancer, or neurodegenerative, metabolic, inflammatory, and autoimmune diseases. Recent advances in our knowledge of the complex biology of lysosomes have established them as promising therapeutic targets for the treatment of different pathologies. Although recent discoveries have started to highlight that lysosomes are controlled by a complex web of regulatory networks, which in some cases seem to be cell- and stimuli-dependent, to harness the full potential of lysosomes as therapeutic targets, we need a deeper understanding of the little-known signalling pathways regulating this subcellular compartment and its functions., This work was supported by “Project PGC2018-096049-B-I00, financiado por: FEDER/Ministerio de Ciencia eI Innovación—Agencia Estatal de Investigación”. This work was also supported by the Regional Government of Andalusia (BIO198, US-1254317 US/JUNTA/FEDER, UE, US-1257019 US/JUNTA/FEDER/UE, P18-FR-3487 and P18-HO-5091) and the Ramón Areces Foundation (2021-2023). JMF is supported by an EU Marie Skłodowska Curie Action (MSCA) Individual Fellowship (CytoLysoReg101025429). We extend our thanks to Dr. Reyes Sanles Falagan for critical reading of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nucleus-translocated mitochondrial cytochrome c liberates nucleophosmin-sequestered ARF tumor suppressor by changing nucleolar liquid-liquid phase separation

  • González-Arzola, Katiuska
  • Díaz-Quintana, Antonio
  • Bernardo-García, Noelia
  • Martínez-Fábregas, Jonathan
  • Rivero-Rodríguez, Francisco
  • Casado-Combreras, Miguel Á.
  • Elena-Real, Carlos A.
  • Velázquez-Cruz, Alejandro
  • Gil-Caballero, Sergio
  • Velázquez-Campoy, Adrián
  • Szulc, Elzbieta
  • Gavilán, María P.
  • Ayala, Isabel
  • Arranz, Rocío
  • Ríos, Rosa M.
  • Salvatella, Xavier
  • Valpuesta, José M.
  • Hermoso, Juan A.
  • Rosa, Miguel A. de la
  • Díaz-Moreno, Irene
32 pags., 17 figs., 1 tab., The regular functioning of the nucleolus and nucleus-mitochondria crosstalk are considered unrelated processes, yet cytochrome c (Cc) migrates to the nucleus and even the nucleolus under stress conditions. Nucleolar liquid-liquid phase separation usually serves the cell as a fast, smart mechanism to control the spatial localization and trafficking of nuclear proteins. Actually, the alternative reading frame (ARF), a tumor suppressor protein sequestered by nucleophosmin (NPM) in the nucleoli, is shifted out from NPM upon DNA damage. DNA damage also triggers early translocation of respiratory Cc to nucleus before cytoplasmic caspase activation. Here, we show that Cc can bind to nucleolar NPM by triggering an extended-to-compact conformational change, driving ARF release. Such a NPM-Cc nucleolar interaction can be extended to a general mechanism for DNA damage in which the lysine-rich regions of Cc-rather than the canonical, arginine-rich stretches of membrane-less organelle components-controls the trafficking and availability of nucleolar proteins., We thank the staf at the NMR facility at CITIUS (University of Seville), the microscopy facility at CABIMER (Seville) and the ALBA Synchrotron (Barcelona). We are grateful to the Spanish Government (grant nos. PID2021-126663NB-I00, PGC2018-096049-B-I00/FEDER, BIO2015-70092-R, BFU2015-71017/BMC, BFU2016-75984/BMC, PID2019-105872GB and BFU2017-90030-P, FEDER/Ministerio de Ciencia e Innovación–Agencia Estatal de Investigación), European Regional Development Fund (FEDER), the Regional Government of Andalusia (grant nos. BIO-198; US-1254317, US-1257019, P18-FR-3487 and P18-HO-4091, US/JUNTA/FEDER, UE), the European Commission: European Regional Development Fund and European Research Council (CONCERT, contract number 648201) and the Ramón Areces Foundation. This work has been supported by Infrastructure for NMR, EM and X-rays for Translational Research (iNEXT, grant no. PID 3407) funded by the Horizon 2020 program of the European Commission, Cámara Foundation (C.A.E.R.´s fellowship), the Spanish Ministry of Education, Culture and Sports (grant nos. FPU18/06577, FPU16/01513 and FPU013/04373; M.A.C.-C., A.V.-C. and F.R.-R.’s fellowships, respectively), La Caixa Foundation (E.S.’s fellowship), Severo Ochoa Award of Excellence from MINECO (Government of Spain, IRB Barcelona and CNB Madrid) and the Spanish Association Against Cancer Scientific Foundation (FC AECC, M.P.G.’s postdoctoral grant), Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

PP2A is activated by cytochrome c upon formation of a diffuse encounter complex with SET/TAF-Iβ

  • Casado-Combreras, Miguel Á.
  • Rivero-Rodríguez, Francisco
  • Elena-Real, Carlos A.
  • Molodenskiy, Dmitry
  • Díaz-Quintana, Antonio
  • Martinho, Marlène
  • Gerbaud, Guillaume
  • González-Arzola, Katiuska
  • Velázquez-Campoy, Adrián
  • Svergun, Dimitri
  • Balle, Valèrie
  • Rosa, Miguel A. de la
  • Díaz-Moreno, Irene
Intrinsic protein flexibility is of overwhelming relevance for intermolecular recognition and adaptability of highly dynamic ensemble of complexes, and the phenomenon is essential for the understanding of numerous biological processes. These conformational ensembles—encounter complexes—lack a unique organization, which prevents the determination of well-defined high resolution structures. This is the case for complexes involving the oncoprotein SET/template-activating factor-Iβ (SET/TAF-Iβ), a histone chaperone whose functions and interactions are significantly affected by its intrinsic structural plasticity. Besides its role in chromatin remodeling, SET/TAF-Iβ is an inhibitor of protein phosphatase 2A (PP2A), which is a key phosphatase counteracting transcription and signaling events controlling the activity of DNA damage response (DDR) mediators. During DDR, SET/TAF-Iβ is sequestered by cytochrome c (Cc) upon migration of the hemeprotein from mitochondria to the cell nucleus. Here, we report that the nuclear SET/TAF-Iβ:Cc polyconformational ensemble is able to activate PP2A. In particular, the N-end folded, globular region of SET/TAF-Iβ (a.k.a. SET/TAF-Iβ ΔC)—which exhibits an unexpected, intrinsically highly dynamic behavior—is sufficient to be recognized by Cc in a diffuse encounter manner. Cc-mediated blocking of PP2A inhibition is deciphered using an integrated structural and computational approach, combining small-angle X-ray scattering, electron paramagnetic resonance, nuclear magnetic resonance, calorimetry and molecular dynamics simulations., This work was supported by Ministry of Science and Innovation (PID2021-126663NB-I00, PGC2018-096049-B-I00 and BFU2015-71017), European Regional Development Fund (FEDER), Andalusian Government (BIO-198, US-1254317, US-1257019, P18-FR-3487 and P18-HO-4091), University of Seville (VI PPIT) and the Ramón Areces Foundation. This work was also supported by Ministry of Education and Professional Training (FPU18/06577 and FPU013/04373 for M. A. C. C. and F. R. R., respectively), Biointeractomicts Platform (cicCartuja, Seville) and the NMR Services at CITIUS (University of Seville). D. M. and D. S. acknowledge the support by the German Federal Ministry of Education and Research, project FKZ 16QK10A. For EPR studies, financial support from the IR INFRANALYTICS FR2054 for conducting the research is gratefully acknowledged. Authors also thank the COST MOBIEU (CA15126) for support in Short Term Scientific Missions. Molecular graphics and analyses performed with UCSF Chimera, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from NIH P41-GM103311. Authors thank Prof. M. Horikoshi for the kind gift of the plasmid encoding SET/TAF-Iβ ΔC. Authors also acknowledge Mr. Abraham Muñiz-Chicharro for his invaluable support with computational work., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cytochrome c lysine acetylation regulates cellular respiration and cell death in ischemic skeletal muscle

  • Morse, Paul T
  • Pérez-Mejías, Gonzalo
  • Wan, Junmei
  • Turner, Alice A
  • Márquez, Inmaculada
  • Kalpage, Hasini A
  • Vaishnav, Asmita
  • Zurek, Matthew P
  • Huettemann, Philipp P
  • Kim, Katherine
  • Arroum, Tasnim
  • Rosa, Miguel A. de la
  • Chowdhury, Dipanwita Dutta
  • Lee, Icksoo
  • Brunzelle, Joseph S
  • Sanderson, Thomas H
  • Malek, Moh H
  • Meierhofer, David
  • Edwards, Brian F P
  • Díaz-Moreno, Irene
  • Hüttemann, Maik
Skeletal muscle is more resilient to ischemia-reperfusion injury than other organs. Tissue specific post-translational modifications of cytochrome c (Cytc) are involved in ischemia-reperfusion injury by regulating mitochondrial respiration and apoptosis. Here, we describe an acetylation site of Cytc, lysine 39 (K39), which was mapped in ischemic porcine skeletal muscle and removed by sirtuin5 in vitro. Using purified protein and cellular double knockout models, we show that K39 acetylation and acetylmimetic K39Q replacement increases cytochrome c oxidase (COX) activity and ROS scavenging while inhibiting apoptosis via decreased binding to Apaf-1, caspase cleavage and activity, and cardiolipin peroxidase activity. These results are discussed with X-ray crystallography structures of K39 acetylated (1.50 Å) and acetylmimetic K39Q Cytc (1.36 Å) and NMR dynamics. We propose that K39 acetylation is an adaptive response that controls electron transport chain flux, allowing skeletal muscle to meet heightened energy demand while simultaneously providing the tissue with robust resilience to ischemia-reperfusion injury., This work was supported by the National Institutes of Health grants R01 GM116807 (M.H.) and R01 NS120322 (M.H.), a Competitive Graduate Research Assistant Award from the Wayne State University Graduate School (P.T.M), and research grants from the Spanish Ministry of Science and Innovation (PGC2018-096049-B-I00 and PID2021-126663NB-I00; I.D-M.), European Regional Development Fund (FEDER; I.D-M.), Andalusian Government (BIO-198, US-1254317, US-1257019, P18-FR-3487, and P18HO-4091, US/JUNTA/FEDER, UE; I.D-M), University of Seville (VI PPIT) and the Ramón Areces Foundation (I.D-M.). G.P-M. was awarded a Ph.D. fellowship from the Spanish Ministry of Education, Culture, and Sport (FPU17/04604). This research used resources from the Advanced Photon Source, a U.S. Department of Energy Office of Science User Facility operated for the Department of Energy Office of Science by Argonne National Laboratory under Contract DE-AC02- 06CH11357. Use of the Life Sciences Collaborative Access Team (LS-CAT) Sector 21 was supported by the Michigan Economic Development Corp., the Michigan Technology Tri-Corridor (Grant 085P1000817; M.H.), and Wayne State University’s Office of the Vice-President for Research (M.H.). We thank Dr. Carlos Moraes at the University of Miami for providing the Cytc double knockout cell line, Beata Lukaszewska-McGreal for proteome sample preparation, and Dr. Pavel Afonine for an alternate script for Phenix. refine, Philippe Archambault of the Chemical Computing Group for his technical advice, the support of the Max Planck Society, and the staff from the NMR facility at CITIUS (University of Seville)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

GWAS of genetic factors affecting white blood cell morphological parameters in Sardinians uncovers influence of chromosome 11 innate immunity gene cluster on eosinophil morphology

  • Marongiu, Michele
  • Pérez-Mejías, Gonzalo
  • Orrù, Valeria
  • Steri, Maristella
  • Sidore, Carlo
  • Díaz-Quintana, Antonio
  • Mulas, Antonella
  • Busonero, Fabio
  • Maschio, Andrea
  • Walter, Klaudia
  • Tardaguila, Manuel
  • Akbari, Parsa
  • Soranzo, Nicole
  • Fiorillo, Edoardo
  • Gorospe, Myriam
  • Schlessinger, David
  • Díaz-Moreno, Irene
  • Cucca, Francesco
  • Zoledziewska, Magdalena
Few genome-wide association studies (GWAS) analyzing genetic regulation of morphological traits of white blood cells have been reported. We carried out a GWAS of 12 morphological traits in 869 individuals from the general population of Sardinia, Italy. These traits, included measures of cell volume, conductivity and light scatter in four white-cell populations (eosinophils, lymphocytes, monocytes, neutrophils). This analysis yielded seven statistically significant signals, four of which were novel (four novel, PRG2, P2RX3, two of CDK6). Five signals were replicated in the independent INTERVAL cohort of 11 822 individuals. The most interesting signal with large effect size on eosinophil scatter (P-value = 8.33 x 10-32, beta = -1.651, se = 0.1351) falls within the innate immunity cluster on chromosome 11, and is located in the PRG2 gene. Computational analyses revealed that a rare, Sardinian-specific PRG2:p.Ser148Pro mutation modifies PRG2 amino acid contacts and protein dynamics in a manner that could possibly explain the changes observed in eosinophil morphology. Our discoveries shed light on genetics of morphological traits. For the first time, we describe such large effect size on eosinophils morphology that is relatively frequent in Sardinian population., Intramural Research Program of the National Institute on Aging (N01-AG-1-2109 and HHSN271201100005C); National Institutes of Health (NIH); by research grants from the Ministry of Science and Innovation (PGC2018-096049-B-I00); European Regional Development Fund (FEDER); Andalusian Government (BIO-198, US-1254317, US-1257019, P18-FR-3487 and P18HO-4091, US/JUNTA/FEDER, UE), University of Seville (VI PPIT) and the Ramón Areces Foundation. G.P.-M. was awarded a PhD fellowship from the Spanish Ministry of Education, Culture and Sport (FPU17/04604)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The Histone Chaperones SET/TAF-1β and NPM1 Exhibit Conserved Functionality in Nucleosome Remodeling and Histone Eviction in a Cytochrome c-Dependent Manner

  • Buzón, Pedro
  • Velázquez-Cruz, Alejandro
  • Corrales-Guerrero, Laura
  • Díaz-Quintana, Antonio
  • Díaz-Moreno, Irene
  • Roos, Wouter H
Chromatin homeostasis mediates essential processes in eukaryotes, where histone chaperones have emerged as major regulatory factors during DNA replication, repair, and transcription. The dynamic nature of these processes, however, has severely impeded their characterization at the molecular level. Here, fluorescence optical tweezers are applied to follow histone chaperone dynamics in real time. The molecular action of SET/template-activating factor-Iβ and nucleophosmin 1-representing the two most common histone chaperone folds-are examined using both nucleosomes and isolated histones. It is shown that these chaperones present binding specificity for fully dismantled nucleosomes and are able to recognize and disrupt non-native histone-DNA interactions. Furthermore, the histone eviction process and its modulation by cytochrome c are scrutinized. This approach shows that despite the different structures of these chaperones, they present conserved modes of action mediating nucleosome remodeling., This work was supported by a Vidi grant of NWO (to W.H.R.), an FPU predoctoral contract of the Spanish Ministry of Education, Culture and Sports (FPU016/01513, to A.V.C.), a postdoctoral contract of the European Social Fund (PAIDI-DOCTOR 2020 DOC_00796, to L.C.G.), a travel grant of EMBO (Short-Term Fellowship 8541, to A.V.C.) and a travel grant of the European ARBRE-Mobieu consortium (COST Action CA15126, to A.D.Q.). The authors are grateful to the Spanish Ministry of Science and Innovation (PGC 2018-096049- BI00 and PID2021-126663NB-100), the Regional Government of Andalusia (BIO198, US-1254317 US/JUNTA/FEDER,UE, P18-FR-3487 and P18–HO-4091) and the Ramón Areces Foundation (2021-2024). The authors thank Gonzalo Pérez-Mejías and Manuel Angulo for their assistance in the NMR measurements at CITIUS (University of Seville). The authors also thank Gijs Wuite, Rifka Vlijm, Katiuska González-Arzola, and Jonathan Martínez-Fábregas for critical feedback on the manuscript and discussions., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cancer-Stem-Cell Phenotype-Guided Discovery of a Microbiota-Inspired Synthetic Compound Targeting NPM1 for Leukemia

  • Algar, Sergio
  • Vázquez-Villa, Henar
  • Aguilar-Garrido, Pedro
  • Navarro-Aguadero, Miguel Ángel
  • Velasco-Estévez, María
  • Sánchez-Merino, Anabel
  • Arribas-Álvarez, Iván
  • Paradela, Alberto
  • Giner-Arroyo, Rafael L.
  • Tamargo-Azpilicueta, Joaquín
  • Díaz-Moreno, Irene
  • Martínez-López, Joaquín
  • Gallardo, Miguel E.
  • López-Rodríguez, María Luz
  • Benhamú, Bellinda
Topic name Nuclear Protein; Nucleophosmin; Tumor Suppressor Protein Prominence percentile 67.656, The human microbiota plays an important role in human health and disease, through the secretion of metabolites that regulate key biological functions. We propose that microbiota metabolites represent an unexplored chemical space of small drug-like molecules in the search of new hits for drug discovery. Here, we describe the generation of a set of complex chemotypes inspired on selected microbiota metabolites, which have been synthesized using asymmetric organocatalytic reactions. Following a primary screening in CSC models, we identified the novel compound UCM-13369 (4b) whose cytotoxicity was mediated by NPM1. This protein is one of the most frequent mutations of AML, and NPM1-mutated AML is recognized by the WHO as a distinct hematopoietic malignancy. UCM-13369 inhibits NPM1 expression, downregulates the pathway associated with mutant NPM1 C+, and specifically recognizes the C-end DNA-binding domain of NPM1 C+, avoiding the nucleus-cytoplasm translocation involved in the AML tumorological process. The new NPM1 inhibitor triggers apoptosis in AML cell lines and primary cells from AML patients and reduces tumor infiltration in a mouse model of AML with NPM1 C+ mutation. The disclosed phenotype-guided discovery of UCM-13369, a novel small molecule inspired on microbiota metabolites, confirms that CSC death induced by NPM1 inhibition represents a promising therapeutic opportunity for NPM1-mutated AML, a high-mortality disease., This work was supported by grants PID2022-138797OB-I00, PGC2018-096049-B-I00 and PID2021-126663NB-I00 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”; grant PID2019-106279RB-I00 funded by MCIN/AEI/10.13039/501100011033; grant PDC2022-133488-I00 funded by MCIN/AEI/10.13039/501100011033 and by the “European Union NextGenerationEU/PRTR”; grants PI21/00191 and CP19/00140 funded by Instituto de Salud Carlos III; CNIO agreements 2017-2020, 2020-2023 funded by Foundation CRIS contra el Cancer; grants BIO-198 and P18-FR-3487 funded by Junta de Andalucía; VI PPIT program funded by Universidad de Sevilla; and by Ramón Areces Foundation. The authors acknowledge technological support from NMR, mass spectrometry and elemental analysis CAIs (Complutense University of Madrid), Biointeractomicts Platform (cicCartuja, Seville), and the Services at CITIUS (University of Seville). S.A., A.S.-M., I.A.-A. and R.L.G.-A. are grateful to Ministerio de Ciencia e Innovación and Complutense University of Madrid for predoctoral fellowships; M.V.-E. to European Union’s Horizon 2020 for Marie Sklodowska-Curie grant; and P.A.-G. to Fundación Española de Hematología y Hemoterapia for grant. The authors thank Dr. Adrián Velázquez-Campoy at the University of Saragossa for helping in fitting ITC analysis and Prof. Miguel A. De la Rosa at the University of Seville for critical reading of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer

  • Lachiondo-Ortega, Sofía
  • Rejano-Gordillo, Claudia María
  • Simón, Jorge
  • Lopitz-Otsoa, Fernando
  • Delgado, Teresa C.
  • Mazan-Mamczarz, Krystyna
  • Goikoetxea-Usandizaga, Naroa
  • Zapata-Pavas, L. Estefanía
  • García-del Río, Ana
  • Guerra, Pietro
  • Peña-Sanfélix, Patricia
  • Hermán-Sánchez, Natalia
  • Al-Abdulla, Ruba
  • Fernández-Rodríguez, Carmen
  • Azkargorta, Mikel
  • Velázquez-Cruz, Alejandro
  • Guyon, Joris
  • Martín, César
  • Zalamea, Juan Diego
  • Egia-Mendikute, Leire
  • Sanz-Parra, Arantza
  • Serrano-Maciá, Marina
  • González-Recio, Irene
  • Gonzalez-López, Monika
  • Martínez-Cruz, Luis Alfonso
  • Pontisso, Patrizia
  • Aransay, Ana M.
  • Barrio, Rosa
  • Sutherland, James D.
  • Abrescia, Nicola G. A.
  • Elortza, Félix
  • Lujambio, Amaia
  • Banales, Jesús M.
  • Luque, Raúl M.
  • Gahete, Manuel D.
  • Palazón, Asís
  • Ávila, Matías A.
  • Marín, José J. G.
  • De, Supriyo
  • Daubon, Thomas
  • Diaz-Quintana, Antonio
  • Díaz-Moreno, Irene
  • Gorospe, Myriam
  • Rodríguez, Manuel S.
  • Martínez-Chantar, María Luz
© 2024 The Author(s). This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)., The posttranslational modification of proteins critically influences many biological processes and is a key mechanism that regulates the function of the RNA-binding protein Hu antigen R (HuR), a hub in liver cancer. Here, we show that HuR is SUMOylated in the tumor sections of patients with hepatocellular carcinoma in contrast to the surrounding tissue, as well as in human cell line and mouse models of the disease. SUMOylation of HuR promotes major cancer hallmarks, namely proliferation and invasion, whereas the absence of HuR SUMOylation results in a senescent phenotype with dysfunctional mitochondria and endoplasmic reticulum. Mechanistically, SUMOylation induces a structural rearrangement of the RNA recognition motifs that modulates HuR binding affinity to its target RNAs, further modifying the transcriptomic profile toward hepatic tumor progression. Overall, SUMOylation constitutes a mechanism of HuR regulation that could be potentially exploited as a therapeutic strategy for liver cancer., This work was supported by grants to M.L.M.-C. from Departamento de Industria del Gobierno Vasco, Spain; Ministerio de Ciencia e Innovación, Spain (grant no. PID2020-117116RB-I00); European Regional Development Fund (ERDF), EU; and CIBERehd, which is funded by Instituto de Salud Carlos III (ISCIII), Spain. M.L.M.-C. and J.S. received funding from Ministerio de Ciencia e Innovación (grant no. RTC2019-007125-1) and ISCIII (grant no. DTS20/00138). M.L.M.-C. and R.M.L. acknowledge Ministerio de Ciencia e Innovación (grant no. RED2022-134397-T). M.L.M.-C. and J.M.B. were awarded with a grant from Fundación la Caixa, Spain (grant no. HR17-00601). M.L.M.-C., J.M.B., M.A.A., and J.J.G.M. acknowledge financial support from Fundación Científica de la Asociación Española Contra el Cáncer (AECC), Spain. M.S.R. recognizes funding from Fondo Sectorial de Investigación SRE - CONACYT, Mexico (grant no. 0280365); Horizon 2020 Research and Innovation Program funded under Marie Skłodowska-Curie Actions, EU (grant no. 765445); and REPÈRE and Programme de Prématuration from Région Occitanie, France. M.G., S.D., and K.M.-M. were supported by the National Institute on Aging (NIA), National Institutes of Health (NIH), US (grant no. Z01-AG000511-23). I.D.-M. is grateful for the grants received from Junta de Andalucía, Spain (grant no. BIO-198, US-1254317, P18-FR-3487, and P18-HO-4091); Ministerio de Ciencia, Innovación y Universidades, Spain (grant no. PGC2018-096049-BI00); and Fundación Ramón Areces, Spain. T.D. acknowledges Fondation ARC, France (grant no. 208084). J.J.G.M. was supported by Junta de Castilla y León, Spain (grant no. SA063P17); Fundación La Marató TV3, Spain (grant no. 201916-31); ISCIII (grant no. PI19/00819); CIBERehd; and ERDF (grant no. OLD-HEPAMARKER). M.A.A. recognizes Gobierno de Navarra, Spain (grant no. GºNa 42/21); Eurorregión Nueva Aquitania-Euskadi-Navarra, Spain; Ministerio de Ciencia e Innovación (grant no. PID2019-104878RB-I00); and CIBERehd. A.P. expresses gratitude to the European Research Council (ERC), EU (grant no. 804236) for their support. M.D.G. received financial support from Junta de Andalucía (grant no. PEMP-0036-2020 and BIO-0139); Ministerio de Universidades, Spain (grant no. FPU20/03957); ISCIII (grant no. PI20/01301), Fundación Sociedad Española de Endocrinología y Nutrición (FSEEN), Spain; CIBERehd; and CIBERobn, which is also funded by ISCIII. J.M.B. acknowledges Euskadi RIS3 (grant no. 2019222054, 2020333010, and 2021333003) and Elkartek programs from Gobierno Vasco (grant no. KK-2020/00008); ISCIII (grant no. PI18/01075, CPII19/00008, and PI21/00922); CIBERehd; PSC Support, UK; AMMF The Cholangiocarcinoma Charity, UK (grant no. EU/2019/AMMFt/001); Horizon 2020 Research and Innovation Program (grant no. 825510); ERDF; and PSC Partners Seeking a Cure, US. A.L. received financial support from the Damon Runyon-Rachleff Innovation Award, US (grant no. DR52-18) and the MERIT Award (R37) from the National Cancer Institute (NCI), NIH (grant no. R37CA230636). F.E. expresses his gratitude to ProteoRed from ISCIII (grant no. PT13/0001/0027) and CIBERehd. N.G.A.A. was funded by Ministerio de Ciencia, Innovación y Universidades (grant no. RTI2018-095700-B-I00). R.B. acknowledges financial support from Gobierno Vasco (grant no. IT1165-19); Ministerio de Economía, Industria y Competitividad, Spain (grant no. SAF2017-90900-REDT); Ministerio de Economía, Industria y Competitividad, ERDF (grant no. BFU2017-84653-P); Ministerio de Ciencia e Innovación (grant no. PID2020-114178GB-I00); and Horizon 2020 funded under Marie Skłodowska-Curie Actions (grant no. 765445-EU). A.M.A. acknowledges CIBERehd. L.A.M.-C. obtained grants from Ministerio de Economía y Competitividad (grant no. CSD2008-00005); Ministerio de Economía, Industria y Competitividad (grant no. BFU2016-77408-R); ISCIII; and EJP RD, EU (grant no. EJPRD19-040). I.G.-R. was supported by Ministerio de Economía, Industria y Competitividad (grant no. BES-2017-080435 ). M.S.-M. is grateful to the AECC, Sede de Bizkaia, Spain for the financial support. J.D.Z. was awarded with a grant from Ministerio de Economía, Industria y Competitividad (grant no. SEV-2016-0644-18-2). C.M. acknowledges Gobierno Vasco (grant no. IT-1264-19) and Ministerio de Ciencia e Innovación (grant no. PID2022-136788OB-I00). A.V.-C. was supported by Ministerio de Educación, Cultura y Deporte, Spain (grant no. FPU016/01513). C.F.-R. thanks Tekniker, Spain and CIC bioGUNE, Spain for financial support. A.G.-d.R. was funded by Bikaintek program from Gobierno Vasco (grant no. 48-AF-W1-2019-00012). N.G.-U. obtained a grant from Gobierno Vasco. T.C.D. expresses gratitude to AECC. J.S. received financial support from CIBERehd. C.M.R.-G. was supported by Ayudas a la Recualificación Margarita Salas from Universidad de Extremadura, Ministerio de Universidades financed by NextGenerationEU., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A splice-altering homozygous variant in COX18 causes severe sensory-motor neuropathy with oculofacial apraxia

  • Mavillard, Fabiola
  • Guerra-Castellano, Alejandra
  • Guerrero-Gómez, David
  • Rivas Infante, Eloy
  • Cantero, Gloria
  • Servián Morilla, E.
  • Folland, Chiara
  • Ravenscroft, Gianina
  • Martín, Miguel Ángel
  • Miranda-Vizuete, Antonio
  • Cabrera-Serrano, Macarena
  • Díaz-Moreno, Irene
  • Paradas, Carmen
Cytochrome-c oxidase (COX) is part of the mitochondrial complex IV (CIV). COX deficiency is usually associated with tRNA variants, and less frequently with variants in COX assembly factors. Mutations in COX subunits encoded by mitochondrial DNA and nuclear DNA are rare, likely because most of them are associated to very severe phenotypes with early lethality. COX18, an assembly factor of CIV, has long been analyzed as a potential cause of mitochondrial disease. To date, only one patient has been identified carrying a homozygous missense variant in COX18, associated with neonatal encephalo-cardiomyopathy and axonal sensory neuropathy. Here, we describe a 40-year-old patient, asymptomatic until 7 months of age, who presented with progressive muscle weakness resembling spinal muscle atrophy type-2, associated with oculofacial apraxia and dysarthric speech. Electrophysiology analysis highlighted a severe sensory-motor neuropathy. Muscle biopsy showed striking and diffuse decreases of COX staining and a substantial reduction of CIV activity. Muscle biopsy showed no ragged-red fibers, although ultrastructural mitochondrial alterations were evident. A novel homozygous variant (c.598G>A), located in the last nucleotide of exon 3, was detected in COX18 by whole-exome sequencing, which affected the splicing donor site, as demonstrated by cDNA-seq. The patient fibroblasts express a truncated form of COX18 (COX18Δ112-240) capable of assembling CIV and CIV-involving supercomplexes. However, CIV activity was decreased. COX18 full-length (COX18-fl) overexpression partially rescued CIV activity in the patient fibroblasts. The rescue of the null CIV activity in COX18-KO-HEK293 cells by overexpressing of COX18Δ112-240 was significantly lower than in cells with COX18-fl. In addition, cox-18 downregulation in C. elegans resulted in slow growth and, diminished reduced motility phenotypes and as well as severe fragmentation of the mitochondrial network. Our case expands the phenotypes associated with COX18 variants and supports the pathogenic role of COX18 as the cause of a severe encephaloneuropathy syndrome., This work was supported in part by the Instituto de Salud Carlos III (FIS PI19-01497 to C. Paradas), Consejería de Salud y Familia, Junta de Andalucía and Programa Operativo Fondo Social Europeo de Andalucía 2014–2020 (RH0046-2020 to G.C) and Consejería de Salud y Consumo, Junta de Andalucía and Programa Nicolas Monarde (C1-0003-2022 to E.S-M). We also acknowledge the FP7 WeNMR (project# 261572), H2020 West-Life (project# 675858), the EOSC-hub (project# 777536) and the EGI-ACE (project# 101017567) European e-Infrastructure projects for the use of their web portals, which make use of the EGI infrastructure with the dedicated support of CESNET-MCC, INFN-LNL-2, NCG-INGRID-PT, TW-NCHC, CESGA, IFCA-LCG2, UA-BITP, TR-FC1-ULAKBIM, CSTCLOUD-EGI, IN2P3-CPPM, CIRMMP, SURFsara and NIKHEF, and the additional support of the national GRID Initiatives of Belgium, France, Italy, Germany, the Netherlands, Poland, Portugal, Spain, UK, Taiwan and the US Open Science Grid. This work was supported by the Spanish Government (PGC2018-096049-B-I00, FEDER/Ministerio de Ciencia e Innovación — Agencia Estatal de Investigación Grant PID2021-126663NB-I00 funded by MCIN/AEI/10.13039/501100011033 and by ERDF A way of making Europe), European Regional Development Fund (FEDER), Andalusian Government (BIO-198, US/JUNTA/FEDER) and the Ramón Areces Foundation (2021–2024 to I.D.-M.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

DATASET A splice-altering homozygous variant in COX18 causes severe sensory-motor neuropathy with oculofacial apraxia

  • Mavillard, Fabiola
  • Guerra-Castellano, Alejandra
  • Rívas, Eloy
  • Cantero, Gloria
  • Servián Morilla, E.
  • Folland, Chiara
  • Ravenscroft, Gianina
  • Martín, Miguel A.
  • Cabrera-Serrano, Macarena
  • Díaz-Moreno, Irene
  • Paradas-López, Carmen
Cytochrome-c oxidase (COX) is part of the mitochondrial complex IV (CIV). COX deficiency is usually associated with tRNA variants, and less frequently with variants in COX assembly factors. Mutations in COX subunits encoded by mitochondrial DNA and nuclear DNA are rare, likely because most of them are associated to very severe phenotypes with early lethality. COX18, an assembly factor of CIV, has long been analyzed as a potential cause of mitochondrial disease. To date, only one patient has been identified carrying a homozygous missense variant in COX18, associated with neonatal encephalo-cardiomyopathy and axonal sensory neuropathy. Here, we describe a 40-year-old patient, asymptomatic until 7 months of age, who presented with progressive muscle weakness resembling spinal muscle atrophy type-2, associated with oculofacial apraxia and dysarthric speech. Electrophysiology analysis highlighted a severe sensory-motor neuropathy. Muscle biopsy showed striking and diffuse decreases of COX staining and a substantial reduction of CIV activity. Muscle biopsy showed no ragged-red fibers, although ultrastructural mitochondrial alterations were evident. A novel homozygous variant (c.598G>A), located in the last nucleotide of exon 3, was detected in COX18 by whole-exome sequencing, which affected the splicing donor site, as demonstrated by cDNA-seq. The patient fibroblasts express a truncated form of COX18 (COX18Δ112-240) capable of assembling CIV and CIV-involving supercomplexes. However, CIV activity was decreased. COX18 full-length (COX18-fl) overexpression partially rescued CIV activity in the patient fibroblasts. The rescue of the null CIV activity in COX18-KO-HEK293 cells by overexpressing of COX18Δ112-240 was significantly lower than in cells with COX18-fl. In addition, cox-18 downregulation in C. elegans resulted in slow growth and, diminished reduced motility phenotypes and as well as severe fragmentation of the mitochondrial network. Our case expands the phenotypes associated with COX18 variants and supports the pathogenic role of COX18 as the cause of a severe encephaloneuropathy syndrome, The authors acknowledge the patient and his family, as well as the patient association ASENSE for all the support to this work. We also acknowledge the facilities and scientific and technical assistance of CITIUS (University of Seville) and the Biomolecular Mass Spectrometry Service of the Pablo de Olavide University. This work was supported in part by the Instituto de Salud Carlos III (FIS PI19-01497 to C. Paradas), Consejería de Salud y Familia, Junta de Andalucía and Programa Operativo Fondo Social Europeo de Andalucía 2014–2020 (RH0046-2020 to G.C) and Consejería de Salud y Consumo, Junta de Andalucía and Programa Nicolas Monarde (C1-0003-2022 to E.S-M). We also acknowledge the FP7 WeNMR (project# 261572), H2020 West-Life (project# 675858), the EOSC-hub (project# 777536) and the EGI-ACE (project# 101017567) European e-Infrastructure projects for the use of their web portals, which make use of the EGI infrastructure with the dedicated support of CESNET-MCC, INFN-LNL-2, NCG-INGRID-PT, TW-NCHC, CESGA, IFCA-LCG2, UA-BITP, TR-FC1-ULAKBIM, CSTCLOUD-EGI, IN2P3-CPPM, CIRMMP, SURFsara and NIKHEF, and the additional support of the national GRID Initiatives of Belgium, France, Italy, Germany, the Netherlands, Poland, Portugal, Spain, UK, Taiwan and the US Open Science Grid. This work was supported by the Spanish Government (PGC2018-096049-B-I00, FEDER/Ministerio de Ciencia e Innovación — Agencia Estatal de Investigación Grant PID2021-126663NB-I00 funded by MCIN/AEI/10.13039/501100011033 and by ERDF A way of making Europe), European Regional Development Fund (FEDER), Andalusian Government (BIO-198, US/JUNTA/FEDER) and the Ramón Areces Foundation (2021–2024 to I.D.-M.). Some of the authors are part of the European Research Network in Neuromuscular Diseases (EURO-NMD)., Peer reviewed